Committed to Medical Innovations
Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.
Lyndra, Inc. (Lyndra) announced today a partnership with Allergan plc to develop orally administered ultra-long-acting (once-weekly) products for the treatment of Alzheimer’s disease. The basis of the collaboration between the Boston-based startup and Allergan is Lyndra’s innovative sustained-release technology, which has the potential to transform drugs typically dosed daily to once-weekly oral dosing.Read More
Call for Submissions! Philips Wearables Challenge The Philips Wearables Challenge is a call for novel solutions to predict early signs of patient deterioration in order to prevent hospital readmission and escalation in care throughout the patient journey. What cutting edge technologies and systems — wireless wearable sensors, connected devices, continuous, real-time monitoring, data analytics, etc. — can…Read More
The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of Artificial Intelligence. The event will bring together industry-leading CEOs, Partners' HIT experts, investors and deal makers to share perspectives on how cognitive computation, machine learning, and big date are having a transformative impact on patient care.
Innovation Symposium Series
The Innovation Symposium Series is a five-part speaker series focused on navigating the innovation lifecycle. The Symposium Series is a complimentary, invitation-only gathering that encourages innovation and recognizes the entrepreneurial spirit of our research community. It is open to any PHS-affiliated investigator, clinician and administrator working on, or considering, research that will enhance the care continuum, improve the patient experience and increase positive outcomes. Attendees will hear from Innovation staff, HIT experts, investors and deal-makers from industry, venture, government and academia.